Renaissance Capital logo

Celularity (GX Acquisition) Priced, Nasdaq: CELU

Blank check company led by the managing partners of Trimaran Capital Partners (completed 7/16/2021).

Industry: SPAC

First Day Return: +0.6%

Our management team is led by Jay R. Bloom and Dean C. Kehler, our co-Chairmen and Chief Executive Officers. Our management team has guided public and private companies over more than three decades as private equity principals, owners, corporate directors and advisors across a wide variety of industries, including the energy, infrastructure, telecom/media, technology, consumer products and services, financial services, and manufacturing sectors. Through these activities, our management team has developed a broad network of contacts that we believe will be helpful in identifying targets for a potential business combination. Messrs. Bloom and Kehler are Managing Partners of Trimaran Capital Partners, which they co-founded in 1998. Trimaran has managed private equity, collateralized loan obligations and hedge funds (in the case of hedge funds, as sub-advisor). Prior to Trimaran, Messrs. Bloom and Kehler were Managing Directors and Vice Chairmen of CIBC World Markets Corp. (“CIBC”), where they were responsible for CIBC’s United States and European merchant banking activities, which were conducted through the CIBC WG Argosy Merchant Funds (the “CIBC Funds”). In addition, Messrs. Bloom and Kehler were responsible for overseeing CIBC’s United States and European Leveraged Finance businesses, which included financial sponsor coverage; acquisition finance; high yield origination, underwriting, sales and trading; private placements and financial restructuring advisory services.
IPO Data
IPO Date 05/20/2019
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $250
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters New York, NY, United States
Founded 2018
Employees at IPO 4

Celularity (GX Acquisition) (CELU) Performance

Created with Highcharts 10.3.2Chart context menuCELU vs. IPO Index (IPOUSA)Sep 2019Jan 2020May 2020Sep 2020Jan 2021May 2021Sep 2021Jan 2022May 2022Sep 2022Jan 2023May 2023Sep 2023Jan 2024May 2024Sep 2024Jan 2025May 20250%+ 100%+ 200%-100%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index